Barnes & Thornburg Adds Patent Attorney Matthew Gibson in Dallas
Barnes & Thornburg has added Matthew S. Gibson as a partner in the Intellectual Property Department in its Dallas office. He is the seventh addition to the Intellectual Property Department this year, and his move follows on the heels of Jerry Harris’ addition to the group in Dallas in August.
Gibson is a patent attorney who serves clients in the life science industry pursuing technologies such as gene therapies, cell therapies, immunotherapies, next generation DNA sequencing, and traditional small molecule pharmaceuticals. Gibson’s practice spans the entire life cycle of a patent, from procurement to licensing to defending against validity challenges at the U.S. Patent and Trademark Office, including inter partes review proceedings.
Gibson also assists clients during the product development or acquisition process by assessing risk associated with competitor IP and analyzing strength of target IP assets. On the enforcement side, Gibson works with his clients to assess the merits of a potential lawsuit and to develop the litigation strategy.
In addition to his patent practice, Gibson also counsels higher education institutions and for-profit companies on their intellectual property policies and routinely provides counsel on trademark-related matters.
Gibson earned his J.D. from the University of Oklahoma College of Law, his Ph.D. from the University of Oklahoma, and his B.S. from Oklahoma Christian University.
